Pegylated interferon and ribavirin combination therapy for chronic hepatitis C associated with thyroid dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pegylated interferon and ribavirin combination therapy for chronic hepatitis C associated with thyroid dysfunction

Published:2013 Issue:11 Volume:54 Page:731-740
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Kanzo

Author:

Okano Miki,Okuse Chiaki,Yotsuyanagi Hiroshi,Shima Junko,Hattori Nobuhiro,Shigefuku Ryuta,Noguchi Yohei,Hatsugai Moriaki,Nakahara Kazunari,Ikeda Hiroki,Takahashi Hideaki,Matsunaga Kotaro,Matsumoto Nobuyuki,Ishii Toshiya,Sato Akira,Fukuda Yasunobu,Koike Kazuhiko,Suzuki Michihiro,Itoh Fumio

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/54/11/54_731/_pdf

Reference47 articles.

1. 1) Tong MJ, el-Farra NS, Reikes AR, et al. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 1463-1466

2. 2) Hu KQ, Tong MJ. The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States. Hepatology 1999; 29: 1311-1316

3. 3) Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. The Lancet 2001; 358: 958-965

4. 4) Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982

5. 5) McHutchison JG, Everson GT, Gordon SC, et al. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection. N Engl J Med 2009; 360: 1827-1838

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP